BDTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Black Diamond Therapeutics Inc (BDTX) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bearish technical indicators, no recent positive news catalysts, and lacks significant trading trends from insiders or hedge funds. While the analyst rating is positive with an increased price target, the lack of financial data and the absence of strong proprietary trading signals make it prudent to hold off on buying this stock right now.
The stock is in a bearish trend with the MACD histogram below 0 and negatively contracting. RSI indicates the stock is oversold at 15.47, but moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.651 and 1.533, with resistance at 2.033 and 2.151.
Analyst Robert Burns from H.C. Wainwright raised the price target from $10 to $11 and maintained a Buy rating.
No significant trading trends from hedge funds or insiders. No recent news or congress trading data. The stock is in a bearish technical trend, and financial data is unavailable for evaluation.
No financial data available for the latest quarter, making it difficult to assess the company's growth trends.
H.C. Wainwright analyst Robert Burns raised the price target to $11 from $10 and maintained a Buy rating, indicating optimism about the stock's potential.
